PolyPid (NASDAQ:PYPD) Now Covered by Analysts at Roth Capital
Roth Capital initiated coverage on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research report released on Thursday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $9.00 price objective on the stock. Separately, HC Wainwright raised shares of PolyPid to a “buy” rating and set a $11.00 price objective on […]
Roth Capital initiated coverage on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research report released on Thursday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $9.00 price objective on the stock. Separately, HC Wainwright raised shares of PolyPid to a “buy” rating and set a $11.00 price objective on […]
